Fintel reports that on May 22, 2025, Citigroup downgraded their outlook for Becton, Dickinson and (NYSE:BDX) from Buy to Neutral. Analyst Price Forecast Suggests 29.78% Upside As of May 7, 2025, the ...

6 analysts have shared their evaluations of Becton Dickinson (NYSE:BDX) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick ...

The scientific-instrument company Waters will deepen its biological sciences footprint by merging with the biosciences and diagnostic solution business of Becton, Dickinson (BD). The companies value ...

Milford lab equipment maker Waters Corp. will acquire the biosciences and diagnostic solutions unit of the medical technology company Becton, Dickinson and Co. in a stock-and-cash deal valued at $17.5 ...

Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, devices, and interventional products for healthcare institutions, physicians, ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

The market expects Becton Dickinson (BDX) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus ...

Oct 15 (Reuters) - Becton Dickinson (BDX.N), opens new tab said on Wednesday that its Chief Financial Officer Chris DelOrefice will depart the company, effective December 5, after four years at the ...